Evidence map›Paper›PMID 40795766›Full record

ArticleThe journals of gerontology. Series A, Biological sciences and medical sciences2025

Tissue-specific molecular regulation of aging mechanisms with methionine restriction in mice and the potential role of methionine sulfoxide reductase.

Kevin M Thyne, Raechel Camones, Adam B Salmon

Abstract read
In one paragraph

Article in The journals of gerontology. Series A, Biological sciences and medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kevin M ThyneSam and Ann Barshop Institute for Longevity and Aging Studies and Departments of Molecular Medicine and Cellular and Integrative Physiology, University of Texas Health San Antonio, San Antonio, TX, United States.ORCID 0000-0002-9101-0399
Raechel CamonesSam and Ann Barshop Institute for Longevity and Aging Studies and Departments of Molecular Medicine and Cellular and Integrative Physiology, University of Texas Health San Antonio, San Antonio, TX, United States.ORCID 0000-0002-5116-5791
Adam B SalmonSam and Ann Barshop Institute for Longevity and Aging Studies and Departments of Molecular Medicine and Cellular and Integrative Physiology, University of Texas Health San Antonio, San Antonio, TX, United States.ORCID 0000-0002-1475-7843

Funding

TRANSGENIC COREP30AG013319 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI PETER J HORNSBY · 1995 to 2026
$30.6M
San Antonio OAIC - Research Education Component (REC)P30AG044271 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Adam Salmon, Elena Volpi · 2015 to 2026
$14.1M
TRAINING GRANT ON THE BIOLOGY OF AGINGT32AG021890 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Erzsebet Kokovay, JAMES FLOYD NELSON · 2003 to 2026
$11.4M
The role of mTOR inhibition on longevity and healthy aging in a non-human primateR01AG050797 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI SALMON, ADAM · 2015 to 2019
$2.7M
Primary fibroblast resiliency as a predictor of health and lifespan in miceR01AG057431 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI SALMON, ADAM · 2017 to 2021
$1.6M
UTHealth-LINK- A PREP programR25GM130437 · NIGMS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI HOPP, SARAH CHRISTINE, OYAJOBI, BABATUNDE OLUKAYODE · 2020 to 2024
$1.6M
BLRD VA I01 BX004167Geriatric Research, Education and Clinical Center of the South Texas Veterans Health Care SystemNIA NIH HHS P30 AG013319NIA NIH HHS P30 AG044271NIA NIH HHS R01 AG050797NIA NIH HHS R01 AG050797, R01 AG057431, T32 AG021890NIA NIH HHS R01 AG057431NIA NIH HHS T32 AG021890NIGMS NIH HHS R25 GM130437San Antonio Area FoundationVA I01 BX004167
6 · The paper itself

Abstract

Methionine restriction (MR) has many effects on different molecular and physiological systems and pathways associated with aging. However, these outcomes have often been ambiguous across studies, suggesting the context of outcomes, including tissue type or donor sex, may have a significant impact. We have previously shown that methionine sulfoxide reductase A (MsrA) may have discrete roles on aging physiology under MR. Here, we investigated the effect of MR on putative molecular hallmarks of aging, including mitochondrial function and regulation of the intracellular signal hydrogen sulfide, across tissues and in males and females. We found that females tended to have greater changes in mitochondrial oxygen consumption than males with MR, while the effects of MsrA were context-dependent. Mitochondrial hydrogen peroxide production was decreased by MR in hepatic mitochondria from females and only slightly higher with loss of MsrA in both sexes. In contrast, mitochondrial peroxide production was increased in the kidney with MR regardless of sex or MsrA status. Hydrogen sulfide production capacity was increased only in the liver by MR independent of MsrA, though expression of regulators of hydrogen sulfide generation was changed in a tissue-dependent manner that was not altered by MsrA status. Expression of methionine sulfoxide reductases was also impacted by MR, showing changes in expression in a tissue and sex-dependent manner. These results suggest a complex interaction between tissue, sex, diet, and MsrA status.

Indexed as

AgingMethionineMethionine Sulfoxide ReductasesAnimalsFemaleHydrogen PeroxideHydrogen SulfideKidneyLiverMaleMiceMice, Inbred C57BLMitochondriaOxygen ConsumptionSex FactorsHydrogen PeroxideHydrogen SulfideMethioninemethionine sulfoxide reductaseMethionine Sulfoxide ReductasesHydrogen sulfideMitochondriaOxygen consumption rateReactive oxygen speciesTranssulfuration

Identifiers

PMID40795766
PMCPMC12448830

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.